215 related articles for article (PubMed ID: 17043076)
1. Enhanced preventive programme at a beryllium oxide ceramics facility reduces beryllium sensitisation among new workers.
Cummings KJ; Deubner DC; Day GA; Henneberger PK; Kitt MM; Kent MS; Kreiss K; Schuler CR
Occup Environ Med; 2007 Feb; 64(2):134-40. PubMed ID: 17043076
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a program to prevent beryllium sensitization among new employees at a copper-beryllium alloy processing facility.
Thomas CA; Bailey RL; Kent MS; Deubner DC; Kreiss K; Schuler CR
Public Health Rep; 2009; 124 Suppl 1(Suppl 1):112-24. PubMed ID: 19618813
[TBL] [Abstract][Full Text] [Related]
3. Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant.
Henneberger PK; Cumro D; Deubner DD; Kent MS; McCawley M; Kreiss K
Int Arch Occup Environ Health; 2001 Apr; 74(3):167-76. PubMed ID: 11355290
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy of a program to prevent beryllium disease.
Thomas CA; Deubner DC; Stanton ML; Kreiss K; Schuler CR
Am J Ind Med; 2013 Jul; 56(7):733-41. PubMed ID: 23450749
[TBL] [Abstract][Full Text] [Related]
5. Beryllium Exposure Control Program at the Cardiff Atomic Weapons Establishment in the United Kingdom.
Johnson JS; Foote K; McClean M; Cogbill G
Appl Occup Environ Hyg; 2001 May; 16(5):619-30. PubMed ID: 11370940
[TBL] [Abstract][Full Text] [Related]
6. Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant.
Kreiss K; Mroz MM; Zhen B; Wiedemann H; Barna B
Occup Environ Med; 1997 Aug; 54(8):605-12. PubMed ID: 9326165
[TBL] [Abstract][Full Text] [Related]
7. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations.
Kreiss K; Wasserman S; Mroz MM; Newman LS
J Occup Med; 1993 Mar; 35(3):267-74. PubMed ID: 8455096
[TBL] [Abstract][Full Text] [Related]
8. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility.
Schuler CR; Kent MS; Deubner DC; Berakis MT; McCawley M; Henneberger PK; Rossman MD; Kreiss K
Am J Ind Med; 2005 Mar; 47(3):195-205. PubMed ID: 15712254
[TBL] [Abstract][Full Text] [Related]
9. Exposure pathway assessment at a copper-beryllium alloy facility.
Day GA; Dufresne A; Stefaniak AB; Schuler CR; Stanton ML; Miller WE; Kent MS; Deubner DC; Kreiss K; Hoover MD
Ann Occup Hyg; 2007 Jan; 51(1):67-80. PubMed ID: 16844720
[TBL] [Abstract][Full Text] [Related]
10. Beryllium sensitization, chronic beryllium disease, and exposures at a beryllium mining and extraction facility.
Deubner D; Kelsh M; Shum M; Maier L; Kent M; Lau E
Appl Occup Environ Hyg; 2001 May; 16(5):579-92. PubMed ID: 11370937
[TBL] [Abstract][Full Text] [Related]
11. Is total mass or mass of alveolar-deposited airborne particles of beryllium a better predictor of the prevalence of disease? A preliminary study of a beryllium processing facility.
Kent MS; Robins TG; Madl AK
Appl Occup Environ Hyg; 2001 May; 16(5):539-58. PubMed ID: 11370934
[TBL] [Abstract][Full Text] [Related]
12. Sensitization and chronic beryllium disease among workers in copper-beryllium distribution centers.
Stanton ML; Henneberger PK; Kent MS; Deubner DC; Kreiss K; Schuler CR
J Occup Environ Med; 2006 Feb; 48(2):204-11. PubMed ID: 16474270
[TBL] [Abstract][Full Text] [Related]
13. Associations of Metrics of Peak Inhalation Exposure and Skin Exposure Indices With Beryllium Sensitization at a Beryllium Manufacturing Facility.
Virji MA; Schuler CR; Cox-Ganser J; Stanton ML; Kent MS; Kreiss K; Stefaniak AB
Ann Work Expo Health; 2019 Oct; 63(8):856-869. PubMed ID: 31504146
[TBL] [Abstract][Full Text] [Related]
14. Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant.
Madl AK; Unice K; Brown JL; Kolanz ME; Kent MS
J Occup Environ Hyg; 2007 Jun; 4(6):448-66. PubMed ID: 17474035
[TBL] [Abstract][Full Text] [Related]
15. Implications of common and special variation for occupational health: examples from beryllium manufacturing.
Deubner DC
J Occup Environ Med; 2013 Jul; 55(7):839-45. PubMed ID: 23787574
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a preventive program to reduce sensitization at a beryllium metal, oxide, and alloy production plant.
Bailey RL; Thomas CA; Deubner DC; Kent MS; Kreiss K; Schuler CR
J Occup Environ Med; 2010 May; 52(5):505-12. PubMed ID: 20431418
[TBL] [Abstract][Full Text] [Related]
17. A comparison and critique of historical and current exposure assessment methods for beryllium: implications for evaluating risk of chronic beryllium disease.
Kolanz ME; Madl AK; Kelsh MA; Kent MS; Kalmes RM; Paustenbach DJ
Appl Occup Environ Hyg; 2001 May; 16(5):593-614. PubMed ID: 11370938
[TBL] [Abstract][Full Text] [Related]
18. Screening for beryllium disease among construction trade workers at Department of Energy nuclear sites.
Welch L; Ringen K; Bingham E; Dement J; Takaro T; McGowan W; Chen A; Quinn P
Am J Ind Med; 2004 Sep; 46(3):207-18. PubMed ID: 15307119
[TBL] [Abstract][Full Text] [Related]
19. Ultrafine beryllium number concentration as a possible metric for chronic beryllium disease risk.
McCawley MA; Kent MS; Berakis MT
Appl Occup Environ Hyg; 2001 May; 16(5):631-8. PubMed ID: 11370941
[TBL] [Abstract][Full Text] [Related]
20. Beryllium medical surveillance at a former nuclear weapons facility during cleanup operations.
Sackett HM; Maier LA; Silveira LJ; Mroz MM; Ogden LG; Murphy JR; Newman LS
J Occup Environ Med; 2004 Sep; 46(9):953-61. PubMed ID: 15354061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]